Not Yet Recruiting
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
NCT07418034
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Communicable Diseases, +38 more
- Locations
-
Not specified